Mindteck (India) Limited provides rendering engineering and IT services in the United States, India, and internationally. The company offers product engineering, embedded design systems, and the Internet of Things, testing, optimisation, and security; product lifecycle and reliability management, digital transformation and smart solutions, renewable energy digital transformation; medical devices and healthcare, such as Next-Gen remote patient, post-operative heart health monitoring, web/cloud-based patient monitoring platform, cloud-integrated AED solution, and cybersecurity and penetration testing. The company also offers analytical instruments, including business intelligence for laboratory instruments, informatics platform for lab automation, and remote scientific data review system; data storage, includes data migration tool development, full stack development, and cloud storage development and testing; semiconductor, such as common cluster tool controller (CTC) framework, enterprise data management platform, cloud-based document solutions, wafer defect classification using deep learning, and LLM-based risk assessment; and testing, such as platform-independent automation tool, mobile test and BDD-based cloud test framework. In addition, the company offers infrastructure services, such as data center management, network, security and desktop management. It serves the medical device and healthcare, life science and analytical instruments, semiconductor, and data storage industries; and government. The company was formerly known as Hinditron Informatics Limited and changed its name to Mindteck (India) Limited in September 1999. The company was incorporated in 1991 and is based in Bengaluru, India. Mindteck (India) Limited is a subsidiary of Embtech Holdings Limited.
Metrics to compare | MDTK | Sector Sector - Average of metrics from a broad group of related Technology sector companies | Relationship RelationshipMDTKPeersSector | |
---|---|---|---|---|
P/E Ratio | 23.0x | 24.3x | 11.8x | |
PEG Ratio | 4.63 | 0.42 | 0.01 | |
Price/Book | 2.5x | 4.1x | 2.4x | |
Price / LTM Sales | 1.6x | 2.4x | 2.2x | |
Upside (Analyst Target) | - | 9.8% | 18.7% | |
Fair Value Upside | Unlock | 13.1% | 5.4% | Unlock |